These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25027226)

  • 21. Does an interferon-gamma release assay change practice in possible latent tuberculosis?
    Tiernan JF; Gilhooley S; Jones ME; Chalmers JD; McSparron C; Laurenson IF; Hill AT
    QJM; 2013 Feb; 106(2):139-46. PubMed ID: 23159840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening and monitoring of latent tubercular infection in patients taking tumor necrosis factor-α blockers for psoriatic arthritis.
    Sanduzzi A; Bocchino M; Atteno M; Costa L; Ponticiello A; Matarese A; Spanò A; Bruner V; Peluso R; Aquino MM; Del Puente A; Scarpa R
    J Rheumatol Suppl; 2012 Jul; 89():82-5. PubMed ID: 22751601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of the tuberculin skin test and interferon-γ release assays: an update on the accuracy, cutoff stratification, and new potential immune-based approaches.
    Goletti D; Sanduzzi A; Delogu G
    J Rheumatol Suppl; 2014 May; 91():24-31. PubMed ID: 24788997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tuberculosis screening in Portuguese healthcare workers using the tuberculin skin test and the interferon-gamma release assay.
    Torres Costa J; Sá R; Cardoso MJ; Silva R; Ferreira J; Ribeiro C; Miranda M; Plácido JL; Nienhaus A
    Eur Respir J; 2009 Dec; 34(6):1423-8. PubMed ID: 19948911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term performance of the IGRA to predict and prevent active tuberculosis development in HIV-infected patients.
    Lee S; Lee JE; Kang JS; Lee SO; Lee SH
    Int J Tuberc Lung Dis; 2019 Apr; 23(4):422-427. PubMed ID: 31064620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic changes in positive interferon-gamma release assay in a dialysis population: An observational cohort study.
    Shu CC; Wu VC; Yang FJ; Hsu CL; Pan SC; Wang JY; Wang JT; Yu CJ; Lee LN
    J Infect; 2013 Dec; 67(6):529-35. PubMed ID: 23933475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Should all patients undergoing treatment with biologic agents be screened annually for latent tuberculosis infection with an interferon gamma release assay?
    Johnson MG; Bialas RW; Hall RP; Stout JE
    J Dermatolog Treat; 2016 Aug; 27(4):378-80. PubMed ID: 26652171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An observational study on prevalence of latent tuberculosis infection and outcome of 3HP treatment in patients under hemodialysis in Taiwan.
    Wu CH; Su HA; Chou CA; Liu JW; Lee CT; Dai LH; Yang CC
    J Formos Med Assoc; 2021 Jun; 120(6):1350-1360. PubMed ID: 34074499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumour necrosis factor antagonist and tuberculosis in patients with rheumatoid arthritis: an Asian perspective.
    To KW; Reino JJ; Yoo DH; Tam LS
    Respirology; 2013 Jul; 18(5):765-73. PubMed ID: 23627398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [FACTORS ASSOCIATED WITH CHANGES IN THE NUMBER OF LATENT TUBERCULOSIS INFECTION NOTIFICATIONS IN JAPAN: NATIONWIDE SURVEY FINDINGS].
    Ohkado A; Yoshimatsu S; Uchimura K; Kato S
    Kekkaku; 2015 Oct; 90(10):657-63. PubMed ID: 26821394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of USP18 and IL2RA Is Increased in Individuals Receiving Latent Tuberculosis Treatment with Isoniazid.
    de Oyarzabal E; García-García L; Rangel-Escareño C; Ferreyra-Reyes L; Orozco L; Herrera MT; Carranza C; Sada E; Juárez E; Ponce-de-León A; Sifuentes-Osornio J; Wilkinson RJ; Torres M
    J Immunol Res; 2019; 2019():1297131. PubMed ID: 31886294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for latent tuberculosis infection in South Korean healthcare workers using a tuberculin skin test and whole blood interferon-gamma assay.
    Jong Lee K; Ae Kang Y; Mi Kim Y; Cho SN; Wook Moon J; Suk Park M; Kyu Kim S; Chang J; Sam Kim Y
    Scand J Infect Dis; 2010 Sep; 42(9):672-8. PubMed ID: 20482459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of the T-SPOT.TB assay to screen latent tuberculosis infection among the TB contacts in Shanghai, China.
    Hu Y; Zhao Q; Graviss EA; Jiang W; Yuan Z; Xu B
    J Infect; 2012 Jul; 65(1):39-48. PubMed ID: 22484244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testing for latent tuberculosis infection using interferon gamma release assays in commercial sex workers at an outreach clinic in Birmingham.
    Daly R; Khatib N; Larkins A; Dedicoat M
    Int J STD AIDS; 2016 Jul; 27(8):676-9. PubMed ID: 26589629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of comorbidities on the performance of interferon-gamma release assay in an elderly Greek population without overt immunodeficiency.
    Tsilika M; Antonakos N; Gkavogianni T; Karageorgos A; Kyriazopoulou E; Netea MG; Giamarellos-Bourboulis EJ
    Int J Antimicrob Agents; 2020 Sep; 56(3):106073. PubMed ID: 32629117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-gamma release assay vs. tuberculin skin test.
    Laffitte E; Janssens JP; Roux-Lombard P; Thielen AM; Barde C; Marazza G; Panizzon RG; Saurat JH
    Br J Dermatol; 2009 Oct; 161(4):797-800. PubMed ID: 19659473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IGRA-Based Screening for Latent Tuberculosis Infection in Persons Newly Incarcerated in New York City Jails.
    Katyal M; Leibowitz R; Venters H
    J Correct Health Care; 2018 Apr; 24(2):156-170. PubMed ID: 29633660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High rate of completion of preventive therapy for latent tuberculosis infection among asylum seekers in a Swiss Canton.
    Sarivalasis A; Bodenmann P; Langenskiold E; Lutchmaya-Flick C; Daher O; Zellweger JP
    Swiss Med Wkly; 2013; 143():w13860. PubMed ID: 24018940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Who must have tuberculosis screening? Characteristics of risk patients].
    MMW Fortschr Med; 2013 May; 155(9):16-8. PubMed ID: 23951641
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.